Smead Capital reports 12.16M Macerich shares (4.74%)

Smead Capital Management filed an amendment reporting beneficial ownership of 12,155,332.57 shares of Macerich Company common stock, representing 4.74% of the class.

Rhea-AI Filing Summary

Smead Capital Management filed an amendment reporting beneficial ownership of 12,155,332.57 shares of Macerich Company common stock, representing 4.74% of the class. The filing is a joint Schedule 13G/A amendment signed by Smead Capital, William W. Smead, and Cole W. Smead.

The report lists sole voting and dispositive power over 12,155,332.57 shares and provides the issuer's principal office address in Santa Monica, California.

Insights

Institutional Ownership Specialist

Large passive stake reported: Smead holds 4.74% of Macerich.

The amendment records 12,155,332.57 shares beneficially owned with sole voting and dispositive power. As a Schedule 13G/A filing, this typically indicates an investment manager reporting a passive position rather than an active acquisition intent.

Materiality depends on context: the 4.74% stake is below the 5% threshold that often triggers different disclosure regimes. Subsequent filings could change the picture if ownership crosses regulatory thresholds.

Compliance & SEC Filings Attorney

Filing appears procedurally complete and joint.

The form includes a joint filing statement under Rule 13d-1(k) and signatures from the CI0, CEO, and Chief Compliance Officer. It lists CUSIP 554382101 and the issuer address verbatim.

Investors seeking changes in control or voting coordination should watch for any future amendments that alter percent ownership or disclose coordinated activity.

Key Figures

Beneficial ownership: 12,155,332.57 shares Percent of class: 4.74% CUSIP: 554382101 +1 more

4 metrics

Beneficial ownership 12,155,332.57 shares reported on Schedule 13G/A

Percent of class 4.74% percent of common stock class

CUSIP 554382101 Macerich Company common stock identifier

Filing date (signature) April 22, 2026 date of joint filing signatures

Key Terms

Schedule 13G/A, beneficially owned, joint filing statement

3 terms

Schedule 13G/A regulatory

"Amendment No. 4 SCHEDULE 13G/A"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

beneficially owned financial

"Amount beneficially owned: 12,155,332.57"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

joint filing statement regulatory

"JOINT FILING STATEMENT PURSUANT TO RULE 13d-1(k)"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stake does Smead Capital report in Macerich (MAC)?

Smead Capital reports beneficial ownership of 12,155,332.57 shares, or 4.74% of the class. The Schedule 13G/A amendment lists sole voting and dispositive power over the full share count and identifies CUSIP 554382101.

Does the filing indicate Smead controls voting for the shares?

Yes. The amendment states sole voting power and sole dispositive power over 12,155,332.57 shares. That language shows Smead reports the ability to vote and dispose of the shares it beneficially owns.

Is this a joint filing and who signed it?

Yes. It is a joint filing under Rule 13d-1(k). Signatories include Brian Briggs (Chief Compliance Officer), William W. Smead (Chief Investment Officer), and Cole W. Smead (President & CEO), dated April 22, 2026.

Does the filing imply activist intentions by Smead Capital?

The Schedule 13G/A form typically signals a passive investor position rather than an activist campaign. The amendment does not disclose coordinated or activist intentions; it records ownership and joint filing status only.

What issuer details are included in the amendment?

The issuer is Macerich Company with CUSIP 554382101. The principal executive office is listed as 410 Wilshire Blvd Suite 700, Santa Monica, CA 90401 in the amendment.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/22/2026 - 01:17 PM EDT Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 4)

MACERICH CO

(Name of Issuer)

Common Stock, $0.01 Par Value

(Title of Class of Securities)

554382101

(CUSIP Number)

03/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 554382101

1

Names of Reporting Persons

Smead Capital Management, Inc.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

ARIZONA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 12,155,332.57
6	Shared Voting Power 0.00
7	Sole Dispositive Power 12,155,332.57
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

12,155,332.57

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.74 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

CUSIP Number(s): 554382101

1

Names of Reporting Persons

William W. Smead

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

ARIZONA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 12,155,332.57
6	Shared Voting Power 0.00
7	Sole Dispositive Power 12,155,332.57
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

12,155,332.57

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.74 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

CUSIP Number(s): 554382101

1

Names of Reporting Persons

Cole W. Smead

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

ARIZONA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 12,155,332.57
6	Shared Voting Power 0.00
7	Sole Dispositive Power 12,155,332.57
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

12,155,332.57

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.74 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: MACERICH CO
(b)	Address of issuer's principal executive offices: 410 Wilshire Blvd Suite 700, Santa Monica, CA 90401
Item 2.
(a)	Name of person filing: Smead Capital Management, Inc. William W. Smead Cole W. Smead
(b)	Address or principal business office or, if none, residence: 2502 E Camelback Road, Suite 210, Phoenix, AZ 85016
(c)	Citizenship: USA
(d)	Title of class of securities: Common Stock, $0.01 Par Value
(e)	CUSIP No.: 554382101
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 12,155,332.57
(b)	Percent of class: 4.74%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 12,155,332.57
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 12,155,332.57
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Smead Capital Management, Inc.

Signature:	Brian Briggs
Name/Title:	Brian Briggs | Chief Compliance Officer
Date:	04/22/2026

William W. Smead

Signature:	William W. Smead
Name/Title:	William W. Smead | Chief Investment Officer
Date:	04/22/2026

Cole W. Smead

Signature:	Cole W. Smead
Name/Title:	Cole W. Smead | President & Chief Executive Officer
Date:	04/22/2026

Exhibit Information

JOINT FILING STATEMENT PURSUANT TO RULE 13d-1(k) The undersigned acknowledge and agree that the foregoing statement on SCHEDULE 13G/A, is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on SCHEDULE 13G/A, shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate. Dated: April 22, 2026 Smead Capital Management, Inc. /s/ Brian Briggs Brian Briggs | Chief Compliance Officer William W. Smead /s/ William W. Smead | Chief Investment Officer Cole W. Smead /s/ Cole W. Smead | President & Chief Executive Officer